Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?

被引：1

作者：

Eun, Chang Soo ^{[1
]}

机构：

[1] Hanyang Univ, Guri Hosp, Dept Internal Med, 153 Gyeongchun Ro, Guri 11923, South Korea

来源：

GUT AND LIVER | 2017年 / 11卷 / 01期

关键词：

CROHNS-DISEASE; INFLIXIMAB;

D O I：

10.5009/gnl16574

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

See "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease" by So Yoon Choi, et al. on page 55, Vol. 11. No. 1, 2017

引用

页码：3 / 4

页数：2

共 9 条

[1] Tailoring anti-TNF therapy in IBD: drug levels and disease activity [J].

Ben-Horin, Shomron ;

Chowers, Yehuda .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2014, 11 (04) :243-255

[2] Optimizing anti-TNF treatments in inflammatory bowel disease [J].

Ben-Horin, Shomron ;

Kopylov, Uri ;

Chowers, Yehuda .

AUTOIMMUNITY REVIEWS, 2014, 13 (01) :24-30

[3] Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review [J].

Billioud, Vincent ;

Sandborn, William J. ;

Peyrin-Biroulet, Laurent .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :674-684

[4] Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease [J].

Choi, So Yoon ;

Kang, Ben ;

Lee, Jee Hyun ;

Choe, Yon Ho .

GUT AND LIVER, 2017, 11 (01) :55-61

[5] Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases [J].

Felice, Carla ;

Marzo, Manuela ;

Pugliese, Daniela ;

Papa, Alfredo ;

Rapaccini, Gian Lodovico ;

Guidi, Luisa ;

Armuzzi, Alessandro .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) :1107-1117

[6] Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease [J].

Khanna, R. ;

Sattin, B. D. ;

Afif, W. ;

Benchimol, E. I. ;

Bernard, E. -J. ;

Bitton, A. ;

Bressler, B. ;

Fedorak, R. N. ;

Ghosh, S. ;

Greenberg, G. R. ;

Marshall, J. K. ;

Panaccione, R. ;

Seidman, E. G. ;

Silverberg, M. S. ;

Steinhart, A. H. ;

Sy, R. ;

Van Assche, G. ;

Walters, T. D. ;

Sandborn, W. J. ;

Feagan, B. G. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) :447-459

[7] Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy [J].

Kim, Mi Jin ;

Lee, Woo Yong ;

Choe, Yon Ho .

GUT AND LIVER, 2015, 9 (03) :370-380

[8] Characteristics of Pediatric Inflammatory Bowel Disease in Korea: Comparison with EUROKIDS Data [J].

Lee, Hyeon Ah ;

Suk, Jung Yoon ;

Choi, Sung Youn ;

Kim, Eun Ran ;

Kim, Young-Ho ;

Lee, Chang Kyun ;

Huh, Kyu Chan ;

Lee, Kang Moon ;

Park, Dong Il .

GUT AND LIVER, 2015, 9 (06) :756-760

[9] Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID) [J].

Lee, Kang-Moon ;

Kim, You Sun ;

Seo, Geom Seog ;

Kim, Tae Oh ;

Yang, Suk-Kyun .

INTESTINAL RESEARCH, 2015, 13 (03) :193-207

← 1 →